Overview

Inhaled Beta-2 Agonist Versus Epinephrine For Treatment of Transient Tachypnea of Newborn (TTN)

Status:
Completed
Trial end date:
2015-12-31
Target enrollment:
Participant gender:
Summary
Inhaled Beta-2 Agonist Versus Epinephrine For Treatment of Transient Tachypnea of Newborn: Randomized controlled trial to assess:
Phase:
Phase 1
Details
Lead Sponsor:
Ahmed Noaman
Treatments:
Albuterol
Epinephrine